A microemulsion-based hydrogel formulation containing voriconazole for topical skin delivery
Tóm tắt
Microemulsion-based hydrogels (MBHs) containing voriconazole were prepared as a possible topical delivery system for enhancing drug absorption at the site of action, as well as reducing the frequency of systemic side effects. Microemulsions were prepared with N-methyl-2-pyrrolidone as a surfactant, benzyl alcohol as an oil, and an ethanol/phosphatidylcholine mixture (3:2, w/w) as a cosurfactant. MBHs were prepared by adding carbopol 940 or xanthan gum as a gelling agent. In vitro skin permeation and deposition studies were performed using static vertical diffusion Franz cells and hairless mouse skin. The in vitro permeation data showed that the optimized microemulsion formulations consisting of voriconazole (1 %, w/w) and benzyl alcohol (10 %, w/w) showed significantly higher drug permeation rates and skin deposition compared to propylene glycol (control). However, the addition of a gelling agent did not significantly change the permeation profiles compared to the microemulsions. In vivo skin deposition studies conducted on hairless mice with MBHs also confirmed the superiority of MBHs compared to the control. These results suggested the MBH system to be a promising vehicle for topical delivery of voriconazole.
Tài liệu tham khảo
Bagley DM, Gardner JR, Holland G, Lewis RW, Regnier JF, Stringer DA, Walker AP (1996) Skin irritation: reference chemicals data bank. Toxicol In Vitro 10:1–6
Changez M, Varshney M, Chander J, Dinda AK (2006) Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. Colloid Surf B 50:18–25
Chen H, Chang X, Du D, Li J, Xu H, Yang X (2006) Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int J Pharm 315:52–58
Chen H, Mou D, Du D, Chang X, Zhu D, Liu J, Xu H, Yang X (2007) Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration. Int J Pharm 341:78–84
Ghosh PK, Majithiya RJ, Umrethia ML, Murthy RSR (2006) Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS PharmSciTech 7(3):77
Gulsen D, Chauhan A (2005) Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle. Int J Pharm 292:95–117
Harding DH (2003) Pharmaceutical formulations containing voriconazole. United States Patent 6,632,803, B1
Jadhav KR, Shaikh IM, Ambade KW, Kadam VJ (2006) Applications of microemulsion based drug delivery system. Curr Drug Deliv 3:267–273
Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB (2003) Voriconazole. Clin Ther 25:1321–1381
Johnson LB, Kauffman CA (2003) Voriconazole: a new triazole antifungal agent. Clin Infect Dis 36:630–637
Jung E, Kang YP, Yoon IS, Kim JS, Kwon SW, Chung SJ, Shim CK, Kim DD (2013) Effect of permeation enhancers on transdermal delivery of fexofenadine: in vitro and in vivo evaluation. Int J Pharm 456:362–369
Kim C, Shim J, Han S, Chang I (2002) The skin-permeation-enhancing effect of phosphatidylcholine: caffeine as a model active ingredient. J Cosmet Sci 53:363–374
Kreilgaard M (2002) Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 54(Suppl 1):S77–S98
Lapasin R, Grassi M, Coceani N (2001) Effects of polymer addition on the rheology of o/w microemulsions. Rheol Acta 40:185–192
Lawrence MJ, Rees GD (2000) Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121
Lee PJ, Langer R, Prasad Shastri V (2003) Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res 20:264–269
Lee EA, Balakrishnan P, Song CK, Cho JH, Noh GY, Park CG, Choi AJ, Chung SJ, Shim CK, Kim DD (2010) Microemulsion-based hydrogel formulation of itraconazole for topical delivery. J Pharm Investig 40:305–311
Leveque D, Nivoix Y, Jehl F, Herbrecht R (2006) Clinical pharmacokinetics of voriconazole. Int J Antimicrob Agents 27:274–284
Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A (2003) Microemulsions for topical delivery of estradiol. Int J Pharm 254:99–107
Santos P, Watkinson AC, Hadgraft J, Lane ME (2008) Application of microemulsions in dermal and transdermal drug delivery. Skin Pharmacol Physiol 21:246–259
Sasaki H, Kojima M, Nakamura J, Shibasaki J (1990) Enhancing effect of combining two pyrrolidone vehicles on transdermal drug delivery. J Pharm Pharmacol 42:196–199
Schwarz JS, Weisspapir MR, Friedman DI (1995) Enhanced transdermal delivery of diazepam by submicron emulsion (SME) creams. Pharm Res 12:687–692
Spernath A, Aserin A, Ziserman L, Danino D, Garti N (2007) Phosphatidylcholine embedded microemulsions: physical properties and improved Caco-2 cell permeability. J Control Release 119:279–290
Špiclin P, Homar M, Zupančič-Valant A, Gašperlin M (2003) Sodium ascorbyl phosphate in topical microemulsions. Int J Pharm 256:65–73
Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56:693–918
Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ, Shim CK, Kim DD (2009) Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 140:86–94
Zhu W, Guo C, Yua A, Gao Y, Cao F, Zhai GX (2009) Microemulsion-based hydrogel formulation of penciclovir for topical delivery. Int J Pharm 378:152–158